Cargando…

Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis

BACKGROUND: Circulating microRNA-122 (miR-122) has been recognized as a marker of hepatocellular carcinoma (HCC). The current meta-analysis was performed to quantitatively evaluate the diagnostic performance of circulating miR-122 for HCC. METHODS: Related studies that evaluated the diagnostic perfo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xiao-Fei, Li, Ning, Lin, Dong-Dong, Sun, Li-Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139899/ https://www.ncbi.nlm.nih.gov/pubmed/32309434 http://dx.doi.org/10.1155/2020/5353695

Ejemplares similares

Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma
por: Luo, Jie, et al.
Publicado: (2013)

Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
por: Chun, Kwang-Hoon
Publicado: (2022)

Circulating microRNAs (miR‐16, miR‐22, miR‐122) expression and early diagnosis of hepatocellular carcinoma
por: Fang, Yujia, et al.
Publicado: (2022)

The Predictive Efficacy of Serum Exosomal microRNA-122 and microRNA-148a for Hepatocellular Carcinoma Based on Smart Healthcare
por: Deng, Peng, et al.
Publicado: (2022)

Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC)
por: Shehab-Eldeen, Somaia, et al.
Publicado: (2019)

Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis
por: Liao, Qibin, et al.
Publicado: (2015)

Bioinformatics analysis of gene expression alterations in microRNA-122 knockout mice with hepatocellular carcinoma
por: He, Bosheng, et al.
Publicado: (2017)

microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma
por: Burchard, Julja, et al.
Publicado: (2010)

Circulating microRNA-122 as Potential Biomarker for Detection of Testosterone Abuse
por: Salamin, Olivier, et al.
Publicado: (2016)

Association of circulating microRNA-122 with presence and severity of atherosclerotic lesions
por: Wang, Yu-Long, et al.
Publicado: (2018)

MicroRNA-122 mimic/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma
por: Hassan, Marwa, et al.
Publicado: (2022)

Downregulation of microRNA-122 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by activating epithelial–mesenchymal transition
por: Wang, Nanyao, et al.
Publicado: (2016)

Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells
por: He, Jialin, et al.
Publicado: (2015)

MicroRNA-122 Triggers Mesenchymal-Epithelial Transition and Suppresses Hepatocellular Carcinoma Cell Motility and Invasion by Targeting RhoA
por: Wang, Sheng-Chun, et al.
Publicado: (2014)

MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review
por: Wei, Xiao-yu, et al.
Publicado: (2020)

Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors
por: Franck, Martin, et al.
Publicado: (2020)

MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2021)

The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset
por: Zhang, Yanfang, et al.
Publicado: (2019)

Association of circulating microRNA‐122 and microRNA‐29a with stage of fibrosis and progression of chronic hepatitis in Labrador Retrievers
por: Sakai, Manabu, et al.
Publicado: (2018)

Circulating microRNA-122 in HCV cirrhotic patients with high frequency of genotype 3
por: Ullah, Amin, et al.
Publicado: (2022)

MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma
por: Wang, Xiaofei, et al.
Publicado: (2022)

[Retracted] MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2023)

Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians
por: Youssef, Samar Samir, et al.
Publicado: (2022)

Progress of HOTAIR-microRNA in hepatocellular carcinoma
por: Wang, Bing-rong, et al.
Publicado: (2022)

Liver-specific microRNA-122: Biogenesis and function
por: Jopling, Catherine
Publicado: (2012)

Evaluation of hepatocyte-derived microRNA-122 for diagnosis of acute and chronic hepatitis of dogs
por: Eman, S. R., et al.
Publicado: (2018)

Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma
por: Dhayat, Sameer A., et al.
Publicado: (2015)

Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma
por: Wu, Xiaochang, et al.
Publicado: (2022)

Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma
por: Zhang, Zhu-qing, et al.
Publicado: (2014)

Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes
por: Willeit, Peter, et al.
Publicado: (2017)

Circulating MicroRNA‐122 and Fibrosis Stage Predict Mortality of Japanese Patients With Histopathologically Confirmed NAFLD
por: Akuta, Norio, et al.
Publicado: (2019)

Improving the Detection of Hepatocellular Carcinoma Using Serum AFP Expression in Combination with GPC3 and Micro-RNA MiR-122 Expression
por: Li, Jian, et al.
Publicado: (2019)

Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children
por: Li, Jun, et al.
Publicado: (2016)

microRNA-122 stimulates translation of hepatitis C virus RNA
por: Henke, Jura Inga, et al.
Publicado: (2008)

Sensitivity and specificity of microRNA‐122 for liver disease in dogs
por: Oosthuyzen, W., et al.
Publicado: (2018)

Roles of MicroRNA-122 in Cardiovascular Fibrosis and Related Diseases
por: Liu, Ying, et al.
Publicado: (2020)

MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patients
por: El-Ahwany, Eman G. E., et al.
Publicado: (2019)

Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma
por: Zhang, Ying, et al.
Publicado: (2017)

MicroRNA-122 regulates caspase-8 and promotes the apoptosis of mouse cardiomyocytes
por: Zhang, Z.W., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2cd44vtekje9hq1hf637pte0jb